Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Higher Dose taMOxifen in Premenopausal bREast Cancer Patients: a preoperaTive Window Trial (MORE-T Trial)

NCT04997941 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT04997941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04997941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Higher Dose taMOxifen in Premenopausal bREast Cancer Patients: a preoperaTive Window Trial (MORE-T Trial)
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 21, 2021
Completion date
December 31, 2028
Enrollment
238 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hormone receptor-positive breast cancer, premenopausal breast cancer